Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe neutropenia due to sustained-release procainamide.

R E Hoyt

    Southern Medical Journal
    |September 1, 1987
    PubMed
    Summary

    Sustained-release procainamide for cardiac arrhythmias can cause severe neutropenia. Regular blood counts are recommended during the first three months of treatment to monitor for this serious side effect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antibiotic sensitivity tests on microaerophilic bacteria and on strains of Mycobacterium tuberculosis, using compressed tablets.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Antibiotic sensitivity testing; a survey of commercially available testing sets.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Staphylococcus aureus endocarditis; treatment with penicillin; report of a case.

    California and western medicine·2010
    Same author

    The use of pectin and gelatin in the processing of plasma in the blood bank.

    American journal of clinical pathology·2010
    Same author

    Scleroma; complement fixation test.

    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010
    Same author

    A survey of commercial Rh antiserums.

    American journal of clinical pathology·2010

    Area of Science:

    • Pharmacology
    • Cardiology
    • Hematology

    Background:

    • Sustained-release procainamide is increasingly used for cardiac arrhythmias.
    • Severe neutropenia and fatalities have been linked to these formulations.

    Observation:

    • The specific sustained-release procainamide preparations implicated are not fully identified.
    • Patients may develop severe neutropenia, a dangerous drop in white blood cells.

    Findings:

    • A causal link between sustained-release procainamide and neutropenia is suggested by reported cases.
    • Monitoring is crucial due to the potential for severe adverse events.

    Implications:

    • Complete blood counts every two weeks for the first three months are recommended.
    • Immediate blood counts are advised for patients with unexplained fever or toxic reactions.
    • This monitoring can help prevent severe neutropenia and associated mortality.

    Related Experiment Videos